| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |